Martin Shkreli rose to fame last year when, as CEO of drug company Turing Pharmaceuticals, he bought the rights to the drug Daraprim and jacked up the price by over 5000% overnight. When the news about Daraprim, a drug used to treat toxoplasmosis (a parasitic infection that can develop in young children and some cancer […]
AuthorFinnius Teppett
Author Archive: Finnius Teppett
February 28, 2016